SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-189004
Filing Date
2019-07-03
Accepted
2019-07-03 13:10:57
Documents
3
Period of Report
2019-07-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d694413d8k.htm 8-K 19609
2 EX-99.1 d694413dex991.htm EX-99.1 36163
3 GRAPHIC g694413g0702201649759.jpg GRAPHIC 4135
  Complete submission text file 0001193125-19-189004.txt   62896
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 19940896
SIC: 2834 Pharmaceutical Preparations